Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company NeuroHealing Pharmaceuticals Inc.
DescriptionDopamine D1 and dopamine D2 receptors agonist
Molecular Target Dopamine D1 receptor ; Dopamine D2 receptor
Mechanism of ActionDopamine D1 receptor agonist; Dopamine D2 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationShock / trauma
Indication DetailsImprove functional outcome in patients in a vegetative state following a traumatic brain injury (TBI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today